Last $52.89 USD
Change Today -0.16 / -0.30%
Volume 924.0K
As of 4:15 PM 09/2/14 All times are local (Market data is delayed by at least 15 minutes).

resmed inc (RMD) Snapshot

Open
$53.00
Previous Close
$53.05
Day High
$53.43
Day Low
$52.80
52 Week High
10/22/13 - $57.34
52 Week Low
02/3/14 - $41.52
Market Cap
7.4B
Average Volume 10 Days
644.2K
EPS TTM
$2.43
Shares Outstanding
140.2M
EX-Date
08/19/14
P/E TM
21.8x
Dividend
$1.12
Dividend Yield
1.95%
Current Stock Chart for RESMED INC (RMD)

resmed inc (RMD) Related Businessweek News

No Related Businessweek News Found

resmed inc (RMD) Details

ResMed Inc. develops, manufactures, distributes, and markets medical equipment for the diagnosis, treatment, and management of respiratory disorders, with a focus on sleep-disordered breathing. Its products portfolio includes airflow generators, diagnostic products, mask systems, motors, and headgear, as well as other accessories, such as cold passover humidifiers, carry bags, and breathing circuits; and humidifiers comprising H5i and H4i, which connect with the continuous and variable positive airway pressure, and AutoSet flow generators to humidify and heat the air delivered to the patient to prevent the drying of nasal passages. The company also offers data communications and control products, including EasyCare, ResLink, ResControl, ResControl II, TxControl, ResScan, and ResTraxx modules that facilitate the transfer of data and other information to and from the flow generators. ResMed Inc. markets its products to sleep clinics, home healthcare dealers, and third-party payers. The company sells its products through a network of distributors and direct sales force in approximately 100 countries worldwide. It has a collaboration agreement with Qualcomm Life, Inc. to develop connected health solutions based on 2net and HealthyCircles platforms. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

resmed inc (RMD) Top Compensated Officers

Chief Executive Officer and Director
Total Annual Compensation: $511.2K
President and Chief Operating Officer
Total Annual Compensation: $588.8K
Chief Financial Officer and Principal Account...
Total Annual Compensation: $505.3K
President of SDB Strategic Business Unit
Total Annual Compensation: $385.0K
President of Americas
Total Annual Compensation: $379.8K
Compensation as of Fiscal Year 2013.

resmed inc (RMD) Key Developments

Qualcomm Life, Inc. Collaborates with ResMed, King's Daughters Medical Center, and CareCentrix to Develop Next-Generation Connected Health Solutions

Qualcomm Life, Inc. has announced its collaboration with ResMed, King's Daughters Medical Center, or KDMC, and CareCentrix to develop next-generation connected health solutions powered by Qualcomm Life's transformational 2net and HealthyCircles platforms. By integrating with Qualcomm Life's scalable solutions, these companies now have access to open and interoperable mHealth ecosystems of medical device, applications and service companies in the health care industry. By liberating vital health and biometric data, Qualcomm Life is assisting these companies with the clinical context and exception-based management tools to efficiently enable care team coordination for transitional care and chronic care management. Of note, ResMed is integrating the 2net Hub and Platform with its Astral 100 and Astral 150 life support ventilators to seamlessly capture and transfer near real-time biometric data to the HealthyCircles care coordination platform, which allows care teams to effectively monitor and manage patients by exception. Additionally, ResMed is using HealthyCircles in combination with its continuous positive airway pressure (CPAP) device to enable hospitals and care providers to closely monitor patients to prevent hospital readmissions.

ResMed's New AirSense 10 CPAP and APAP Devices Deliver Superior Patient Comfort and Cost-Saving Efficiency for Healthcare Providers

ResMed introduced its new AirSense(TM) 10 positive-airway pressure (PAP) device platform, with breakthrough features that benefit both the patient and the healthcare provider. The AirSense 10 series PAP devices are the cornerstones of the ResMed Air Solutions connected care platform, an ecosystem of hardware and software solutions that can significantly streamline the patient compliance monitoring and management process while improving overall patient outcomes and engagement. The AirSense 10 series works with ResMed's AirView(TM) patient monitoring software. Formerly called EasyCare Online, AirView seamlessly works with AirSense 10 devices to track, analyze and report a patient's usage and compliance as well as make the device's status visible to healthcare providers. The AirSense 10 series devices are available now in the United States and Australia and include four new devices: AirSense 10 CPAP: ResMed's CPAP device with all of the advanced features that are standard with AirSense 10 series devices (listed below). AirSense 10 Elite: ResMed's step-up CPAP device that includes detection of central sleep apneas and Cheyne-Stokes respiration. AirSense 10 AutoSet(TM): The AirSense 10 AutoSet devices continually monitor breathing, adapting breath by breath to always deliver the lowest therapeutic pressure, improving comfort and sleep. AirSense 10 AutoSet for Her: Women comprise nearly 40% of new patients, and the AirSense 10 AutoSet for Her is the first and only FDA-cleared device that provides specialized sleep apnea therapy for women based upon specific female breathing patterns. It uses a clinically proven algorithm designed to treat mild to moderate sleep apnea in women. Key AirSense 10 series features that break new ground in therapy for sleep-disordered breathing include: Connected care: Every AirSense 10 device is enabled for data on demand with wireless communications out of the box -- no module, SD card, or pairing to a smart phone is necessary. That means that each device is always on, tracking patient therapy data that is available to providers just one hour after the device's last use, facilitating more timely patient interventions. Remote device settings changes and troubleshooting: The power of communications means that healthcare providers can troubleshoot and change settings without the cost of sending staff to check on a device or manually change the therapy settings. And using ResMed's AirView web-based software, providers can view the device's status at a glance and determine whether the device requires service or if instead an issue may be resolved remotely with a click of a mouse. Integrated HumidAir(TM) heated humidification: All ResMed AirSense devices have integrated HumidAir heated humidifiers that afford a more compact bedside footprint. In addition to more comfort and fewer parts to manage for the patient, the integrated humidifier also means less inventory to track for HMEs. AutoRamp: This comfort feature uses sleep onset detection to keep pressure low before delivering full therapy pressure as soon as the patient falls asleep to enhance therapy compliance. Simple, elegant user-friendly controls for patient confidence: ResMed has redesigned and significantly streamlined its user interface to enable patients to operate their devices with more confidence. AirSense 10 series devices also have an angled LCD screen for easy bedside viewing, and an ambient light sensor to adjust to the brightness of the room, so the screen's backlight won't disturb the user or the bed partner during the night.

ResMed Announces New Air Solutions Connected Care Platform for Treating Sleep-Disordered Breathing

ResMed announced Air Solutions, a new forward-thinking connected care solution for treating sleep-disordered breathing that can benefit all stakeholders in the care continuum. The ResMed Air Solutions platform has data-driven components that span from diagnosis to treatment, compliance management and patient engagement. Ecosystem Approach Brings Increased Efficiency and Efficacy to SDB Treatment. Air Solutions comprises components that, together, create a comprehensive end-to-end ecosystem that directly addresses the pain points for each stakeholder in the patient's therapy, including physicians, sleep labs, home medical equipment providers, and the patients themselves. The ecosystem approach, can increase efficiency and treatment efficacy by keeping providers informed and patients engaged. Included in the Air Solutions platform are: ApneaLink(TM) Air: ResMed's compact and lightweight home sleep testing device works seamlessly with AirView software to empower sleep labs to efficiently manage each step of the diagnostic process, and share data to appropriate user groups, AirSense(TM) 10 Series: ResMed's new series of continuous and automatic positive airway pressure devices (CPAP and APAP) called AirSense 10 that have advanced data and communications features to streamline the set-up, compliance management and compliance monitoring processes. This brand new device platform is also intuitive and easy-to-use, and offers a smaller bedside footprint, AirCurve(TM) 10 Series: The AirCurve 10 series includes a range of bi-level devices that meet a variety of patient conditions and needs, such as patients who need extra pressure support, as well as an ASV device for patients with Cheyne-Stokes respiration or who require adaptive-servo-ventilation, AirFit(TM) Masks: Announced earlier this year, the AirFit masks are known by their easy fit and superior comfort, The AirFit line includes the AirFit P10 nasal pillows system the AirFit F10 full-face mask and the AirFit N10 nasal mask, AirView(TM) Monitoring and Compliance Management System: When used in conjunction with Air Solutions devices, the AirView software solution significantly streamlines the patient management process by providing troubleshooting, fault detection and more. AirView enables data on demand, with patient data available in just one hour after a patient's therapy session has ended, myAir Patient Engagement Application and Software: An engaged patient is more likely to be compliant, and myAir helps patients better understand their own sleep data, with data dashboards, coaching and reinforcement messages.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RMD:US $52.89 USD -0.16

RMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RMD.
View Industry Companies
 

Industry Analysis

RMD

Industry Average

Valuation RMD Industry Range
No financial data is available for RMD.
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact RESMED INC, please visit www.resmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.